Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats

Pharmaceutical Biology

Volumn 50, Issue 10, 2012, Pages 1310-1316

  Breivogel, Chris ^a   Jamerson, Brenda ^a,b  

^a CAMPBELL UNIVERSITY   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Addiction; Nicotine; Passiflora incarnata; Sensitization

Indexed keywords

NICOTINE; PASSIFLORA INCARNATA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIZATION; LOCOMOTION; MALE; NICOTINE SENSITIZATION; NONHUMAN; PASSIFLORA INCARNATA; PASSIFLORACEAE; PASSION FLOWER; RAT; TOBACCO DEPENDENCE;

ANIMALS; ARABIDOPSIS PROTEINS; DRUG ADMINISTRATION SCHEDULE; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; NUCLEAR PROTEINS; PASSIFLORA; PLANT EXTRACTS; RATS; RATS, WISTAR; SMOKING CESSATION; TOBACCO USE DISORDER;

NICOTIANA TABACUM; PASSIFLORA; PASSIFLORA INCARNATA; PASSIFLORACEAE; RATTUS;

EID: 84866110054     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.674535     Document Type: Article

References (21)

1. Akhondzadeh S, Kashani L, Mobaseri M, Hosseini SH, Nikzad S, Khani M. (2001a). Passionflower in the treatment of opiates withdrawal: A double-blind randomized controlled trial. J Clin Pharm Ther, 26, 369-373. (Pubitemid 32989559)
2. Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. (2001b). Passion flower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther, 26, 363-367. (Pubitemid 32989558)
3. Benowitz NL. (1996). Pharmacology of nicotine: Addiction and therapeutics. Annu Rev Pharmacol Toxicol, 36, 597-613. (Pubitemid 26168710)
4. Dani JA, De Biasi M. (2001). Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav, 70, 439-446. (Pubitemid 34131638)
5. Dhawan K, Kumar S, Sharma A. (2002). Nicotine reversal effects of the benzoflavone moiety from Passiflora incarnata Linneaus in mice. Addict Biol, 7, 435-441. (Pubitemid 35402518)
6. Dhawan K. (2003). Drug/substance reversal effects of a novel trisubstituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn.-a brief perspective. Addict Biol, 8, 379-386. (Pubitemid 38102044)
7. DiFranza JR, Wellman RJ. (2007). Sensitization to nicotine: How the animal literature might inform future human research. Nicotine Tob Res, 9, 9-20. (Pubitemid 47009040)
8. Fiore M, Jaen CR, Baker TB. Bailey WC, Benett G. (2008). A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med, 35, 158-176.
9. Kayir H, Goktalay G, Yildirim M, Uzbay TI. (2009). Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats. Synapse, 63, 15-21.
10. Krenn L. (2002). [Passion Flower (Passiflora incarnata L.)-a reliable herbal sedative]. Wien Med Wochenschr, 152, 404-406. (Pubitemid 34984933)
11. Ksir C, Hakan RL, Kellar KJ. (1987). Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology (Berl), 92, 25-29. (Pubitemid 17063657)
12. Li Z, DiFranza JR, Wellman RJ, Kulkarni P, King JA. (2008). Imaging brain activation in nicotine-sensitized rats. Brain Res, 1199, 91-99.
13. Moeller DW, Sun LS. (2010). Chemical and radioactive carcinogens in cigarettes: Associated health impacts and responses of the tobacco industry, U.S. Congress, and federal regulatory agencies. Health Phys, 99, 674-679.
14. Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. (2008). Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: A double-blind, placebo-controlled study. Anesth Analg, 106, 1728-1732.
15. Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. (2007). Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: Involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med, 7, 26.
16. Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW. (2006). Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos, 34, 121-130. (Pubitemid 43042653)
17. Paterson NE, Balfour DJ, Markou A. (2007). Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur J Neurosci, 25, 3099-3108. (Pubitemid 46888800)
18. Rennard SI, Daughton DM. (2000). Smoking cessation. Chest, 117, 360S-364S. (Pubitemid 30314467)
19. Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F. (1997). Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J Ethnopharmacol, 57, 11-20. (Pubitemid 27303468)
20. Werneke U, Turner T, Priebe S. (2006). Complementary medicines in psychiatry: Review of effectiveness and safety. Br J Psychiatry, 188, 109-121. (Pubitemid 43171065)
21. Zanoli P, Avallone R, Baraldi M. (2000). Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia, 71 Suppl 1, S117-S123. (Pubitemid 30621704)